| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | CHIEF EXECUTIVE OFFICER, Director | Common Stock | 426K | $16.1M | $37.74 | Mar 10, 2025 | Direct |
| Scholar Rock Holding Corp | CHIEF EXECUTIVE OFFICER, Director | Stock Option (Right to Buy) | 151K | Mar 10, 2025 | Direct | ||
| LAVA Therapeutics NV | Director | Common Shares (Right to Buy) | 33.4K | Feb 13, 2025 | Direct | ||
| AGIOS PHARMACEUTICALS, INC. | Director | Stock options (right to buy) | 23.4K | Jul 8, 2025 | Direct | ||
| Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 7K | Dec 29, 2022 | Direct | ||
| AGIOS PHARMACEUTICALS, INC. | Director | Restricted stock units | 4.34K | Jul 8, 2025 | Direct | ||
| ACCELERON PHARMA INC | EVP, Research and Development | Common Stock | 0 | $175.00 | Nov 19, 2021 | Direct | |
| ACCELERON PHARMA INC | EVP, Research and Development | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
| LAVA Therapeutics NV | Director | Share Options (Right to Buy) | 0 | Nov 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics NV | Nov 13, 2025 | 1 | $0 | 4 | Nov 17, 2025 | Director |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Jul 8, 2025 | 2 | $0 | 4 | Jul 10, 2025 | Director |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Jul 8, 2025 | 0 | $0 | 3 | Jul 10, 2025 | Director |
| SRRK | Scholar Rock Holding Corp | Mar 10, 2025 | 2 | $0 | 4 | Mar 12, 2025 | CHIEF EXECUTIVE OFFICER, Director |
| SRRK | Scholar Rock Holding Corp | Feb 18, 2025 | 1 | -$677K | 4 | Feb 20, 2025 | CHIEF EXECUTIVE OFFICER, Director |
| LVTX | LAVA Therapeutics NV | Feb 13, 2025 | 1 | $0 | 4 | Feb 18, 2025 | Director |
| SRRK | Scholar Rock Holding Corp | Jan 16, 2025 | 1 | -$986K | 4 | Jan 21, 2025 | CHIEF EXECUTIVE OFFICER, Director |
| LVTX | LAVA Therapeutics NV | Jan 1, 2025 | 0 | $0 | 3 | Jan 2, 2025 | Director |
| SRRK | Scholar Rock Holding Corp | Feb 16, 2024 | 1 | -$183K | 4 | Feb 20, 2024 | CHIEF EXECUTIVE OFFICER, Director |
| SRRK | Scholar Rock Holding Corp | Feb 12, 2024 | 2 | $0 | 4 | Feb 13, 2024 | CHIEF EXECUTIVE OFFICER, Director |
| SRRK | Scholar Rock Holding Corp | Feb 13, 2023 | 2 | $0 | 4 | Feb 15, 2023 | CHIEF EXECUTIVE OFFICER |
| IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
| IRON | Disc Medicine, Inc. | Dec 29, 2022 | 0 | $0 | 3 | Jan 3, 2023 | Director |
| SRRK | Scholar Rock Holding Corp | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | CEO-Elect |
| SRRK | Scholar Rock Holding Corp | Sep 20, 2022 | 0 | $0 | 3 | Sep 22, 2022 | CEO-Elect |
| XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 3 | $0 | 4 | Nov 22, 2021 | EVP, Research and Development |